Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for David Penson

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCURO1540

    07/08/2015

    A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men with High-Risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy. MDV3100-13

    Treatment

    VICCURO1450

    08/13/2014

    PROSPER: A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer


    Print this page for your doctor